Get informed when a big investor buys or sells
+ Follow-1.70
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Arctic Bioscience AS (ABS.OL) currently reports a P/E ratio of -1.7. That is below the Healthcare sector average of 28.76. Use the charts on this page to explore Arctic Bioscience AS's P/E ratio history and peer comparisons.
Arctic Bioscience AS's P/E ratio of -1.7 is lower than the Healthcare sector average of 28.76. That is roughly 105.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Arctic Bioscience AS's market price to a fundamental measure such as earnings, sales, or book value. At -1.7, ABS.OL can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -1.7, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 28.76. From there, open related valuation or income-statement pages for Arctic Bioscience AS, and consider following ABS.OL for alerts when major investors trade the stock.
Arctic Bioscience AS is classified in the Healthcare sector. On P/E ratio, it currently shows -1.7 versus a sector average near 28.76. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABS.OL with unrelated industries.